Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?

Journal of Clinical Gastroenterology

Volumn 33, Issue 3, 2001, Pages 206-209

  Farup, Per G ^a   Juul Hansen, P H ^b   Rydning, A ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Rasta Medical Center   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Gastroesophageal reflux disease; Proton pump inhibitors; Rebound aggravation; Symptoms

Indexed keywords

ANTACID AGENT; LANSOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REBOUND; REFLUX ESOPHAGITIS; SHORT COURSE THERAPY; SIDE EFFECT; STOMACH SECRETION; SYMPTOMATOLOGY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; TIME FACTORS;

EID: 0034881434     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200109000-00007     Document Type: Article

References (14)

1. Heartburn treatment in primary care; randomised, double blind study for 8 weeks
2. Healing and relapse of severe peptic esophagitis after treatment with omeprazole
3. 2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output
4. Helicobacter pylori, acid, and omeprazole revisited: Bacterial eradication and rebound hypersecretion
5. Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects
6. Marked rebound acid hypersecretion after treatment with ranitidine
7. Marked increase in gastric acid secretory capacity after omeprazole treatment
8. Rebound hypersecretion after omeprazole and its relation to on- treatment acid suppression and Helicobacter pylori status
9. Personal review: Is profound acid inhibition safe?
10. Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers
11. Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients
12. Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects
13. Dose-response relationship of lansoprazole to gastric acid antisecretory effects
14. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole